|
English
|
正體中文
|
简体中文
|
2825920
|
|
???header.visitor??? :
31403503
???header.onlineuser??? :
969
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"martin aj"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國家衛生研究院 |
2021-09 |
INTEGRATE IIb: A randomised phase III open label study of regorafenib plus nivolumab vs standard chemotherapy in refractory advanced gastro-oesophageal cancer (AGOC)
|
Pavlakis, N;Shitara, K;Sjoquist, K;Martin, AJ;Jaworski, A;Yip, S;Oh, DY;Moehler, M;Chen, LT;Bekaii-Saab, T;Simes, J;Goldstein, D |
| 國家衛生研究院 |
2019-10 |
Randomised phase 3 study of regorafenib in refractory advanced gastro-oesophageal cancer (AGOC) - Integrate II
|
Chua, YJ;Pavlakis, N;Sjoquist, KM;Martin, AJ;Tsobanis, E;Yip, S;Bang, YJ;Alcindor, T;O'Callaghan, CJ;Bekaii-Saab, TS;Grothey, A;Chen, LT;Simes, J;Zalcberg, JR;Goldstein, D;Komatsu, Y;Machida, N;Esaki, T;Hara, H;Shitara, K |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
